Nyxoah
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nyxoah and other ETFs, options, and stocks.About NYXH
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA.
CEOOlivier Taelman
CEOOlivier Taelman
Employees184
Employees184
HeadquartersMont-Saint-Guibert, Walloon Region
HeadquartersMont-Saint-Guibert, Walloon Region
Founded2009
Founded2009
Employees184
Employees184
NYXH Key Statistics
Market cap200.93M
Market cap200.93M
Price-Earnings ratio-1.91
Price-Earnings ratio-1.91
Dividend yield—
Dividend yield—
Average volume19.17K
Average volume19.17K
High today$4.79
High today$4.79
Low today$4.60
Low today$4.60
Open price$4.72
Open price$4.72
Volume38.29K
Volume38.29K
52 Week high$11.87
52 Week high$11.87
52 Week low$4.35
52 Week low$4.35
Stock Snapshot
As of today, Nyxoah(NYXH) shares are valued at $4.71. The company's market cap stands at 200.93M, with a P/E ratio of -1.91.
On 2025-12-23, Nyxoah(NYXH) stock moved within a range of $4.60 to $4.79. With shares now at $4.71, the stock is trading +2.5% above its intraday low and -1.7% below the session's peak.
Trading activity shows a volume of 38.29K, compared to an average daily volume of 19.17K.
The stock's 52-week range extends from a low of $4.35 to a high of $11.87.
The stock's 52-week range extends from a low of $4.35 to a high of $11.87.
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%
People also own
Based on the portfolios of people who own NYXH. This list is generated using Robinhood data, and it’s not a recommendation.